CELSO
ARANGO LÓPEZ
Catedrático de universidad
Javier
Rejas Gutiérrez
Publicaciones en las que colabora con Javier Rejas Gutiérrez (8)
2013
-
A simulation model to estimate 10-year risk of coronary heart disease events in patients with schizophrenia spectrum disorders treated with second-generation antipsychotic drugs
Annals of Clinical Psychiatry, Vol. 25, Núm. 1, pp. 17-26
2012
-
Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: Results from the CLAMORS study
European Psychiatry, Vol. 27, Núm. 4, pp. 267-274
2011
-
Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: Findings from the CLAMORS study
European Neuropsychopharmacology, Vol. 21, Núm. 12, pp. 867-875
2010
-
Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort
Schizophrenia Research, Vol. 119, Núm. 1-3, pp. 101-109
-
Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: Findings from the CLAMORS study
Journal of Clinical Psychiatry, Vol. 71, Núm. 3, pp. 280-286
2008
-
A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study
Schizophrenia Research, Vol. 104, Núm. 1-3, pp. 1-12
-
Concordance of standard and modified NCEP ATP III criteria for identification of metabolic syndrome in outpatients with schizophrenia treated with antipsychotics: A corollary from the CLAMORS study
Schizophrenia Research, Vol. 99, Núm. 1-3, pp. 23-28
2007
-
Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: Results of the CLAMORS Study
Schizophrenia Research, Vol. 90, Núm. 1-3, pp. 162-173